Publications

Le 07 Déc 2020

Publications

Filtrer nos publications par :

2015

Letter by Gauberti and Vivien regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".

Consulter

2011

Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

About 15 million strokes occur each year worldwide. As the number one cause of morbidity and acquired disability, stroke is (…)

Consulter

2021

Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke.

In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activator (rt-PA) is limited by restricted time-window due to (…)

Consulter

2021

New Approaches in Nanomedicine for Ischemic Stroke.

Ischemic stroke, caused by the interruption of blood flow to the brain and subsequent neuronal death, represents one of the (…)

Consulter

2021

Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor-dependent mechanisms.

Factor XII (FXII) is a serine protease that participates in the intrinsic coagulation pathway. Several studies have shown that plasma (…)

Consulter

2021

Thrombolytic strategies for ischemic stroke in the thrombectomy era.

Twenty-five years ago, intravenous thrombolysis has revolutionized the care of patients with acute ischemic stroke. Since 2015, randomized clinical trials (…)